KERENGE AKO-EBOT: Open Payments
NPI 1790443075 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
Products named: ABILIFY ASIMTUFII, INGREZZA.
Industry payments across MN — which companies pay providers there.
